Below, you'll find extensive
information on leading compare life insurance articles and products to help you on
your way to success.
|
Life Insurance - Women Furious Over Insurer Gene Testing
By Charles michael Challiner
Thousands of women with family histories of breast and ovarian cancer could pay higher insurance premiums or even be denied cover altogether under new proposals from the insurance industry.
The Association of British Insurers (ABI) is expected to lodge an application for permission for its members to ask women whether they have been tested for the BRCA1 and BRCA2 mutations.
The faulty BRCA genes are responsible for about five per cent of the 41,700 new cases of breast cancer and 10 per cent of ovarian cancers diagnosed in Britain each year.
If the insurers are granted permission by the Genetics and Insurance Committee (the organisation that advises the Government on the issue), women who have tested positive could be forced to pay higher premiums. Some companies may even refuse high value life or critical illness insurance.
A notice published on the Genetics and Insurance Committee’s website said, “The Committee expects that the Association of British Insurers will submit in late 2006/2007 four revised and updated applications for the use of adverse results from predictive genetic tests of the BRCA1 and BRCA2 genes (breast/ovarian cancer) in helping to determine insurance premiums for life and critical illness insurance.”
At present, the only predictive genetic test the Genetics and Insurance Committee has allowed insurance companies to ask about is for Huntingtons Disease. This is because of the lack of environmental influences on its development.
However, across Europe, several countries have banned insurers from using genetic tests to decide premiums. Also, in 2005, a voluntary agreement to avoid using such tests by British insurance companies was extended until 2011.
Under this agreement, insurers can ask potential customers only about genetic testing results for Huntingtons Disease. However, they can only ask for the information for policies that are worth more than £500,000 for life insurance, more than £300,000 for critical illness and more than £30,000 a year for payment protection.
But The Association of British Insurers’ genetics working party has indicated that it would like to bring about a change seeking permission to ask about two cancer genes and wants approval by the end of the year.
Approximately one in eight hundred and fifty women in Britain inherits a faulty BRCA1 gene. Those women will have a fourteen to eighteen per cent chance of developing breast cancer at some point in their lives.
Meanwhile the insurance companies are not allowed to ask prospective policyholders
Goshen County mosquitoes test positive for West Nile
Beau Bofferding
Gates, Bloomberg pool riches to fight smoking
if they are HIV positive, but they can ask them if they have exposed themselves to the risk of infection through unsafe sex or sharing needles.
An alliance of 45 leading charities, unions and scientists, lawyers have called on the UK Government to ban this genetic discrimination.
A study carried out by the charity Breakthrough Breast Cancer found 28 per cent of women with a family history of breast cancer said the would be deterred from having a genetic test if insurers had access to the results.
Clearly there is a dichotomy here. The insurance industry want to receive as much information as possible about those applying for insurance cover to enable it to assess the risk of a claim as it uses this information to set the applicant’s premium. If the risk is under assessed, then the applicant’s premium will be set too low. On the other hand, applicants do not want to feel that the insurer has the right to use modern medical techniques to delve into every possible aspect of their lives. Article Source: http://articles-galore.com Get great articles on life insurance quotes from Quotes
Products and Services mentioned in this article are available Here  
|
